The RECOVER study is a comparative effectiveness study that prospectively includes patients with high-risk, non-metastatic PCa to compare treatment with robot assisted radical prostatectomy (RARP) versus EBRT combined with ADT. The study is executed by a cooperation of the Netherlands Comprehensive Cancer Organization (IKNL), the Dutch Association for Urology (NVU) and the Dutch Society of Radiotherapy and Oncology (NVRO).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile